Extracorporeal membrane oxygenation (ECMO) can support gas exchange independently of mechanical ventilation in patients with severe acute respiratory failure. ECMO may be used either as a rescue intervention or to minimize ventilator-associated lung injury
1 and its associated multiple organ dysfunction,
2 both crucial determinants of survival for patients with acute respiratory distress syndrome (ARDS).
3 A recent randomized controlled study indicated that significantly more patients with severe ARDS survived without severe disability if they were transferred to a single ECMO center compared with patients who were managed conventionally.
4 However, differences between the centers in mechanical ventilation and other therapies used to manage the conventionally treated patients could have affected outcome independently. Moreover, ECMO doubled hospital costs compared with conventional care.
5 Hence, the role of ECMO in adults with severe ARDS remains controversial.
6-8